Watchdog Report Links Medicaid-Funded Autism Provider to Billing Irregularities and Abuse Claims
A watchdog report alleges that Hopebridge, a Medicaid-funded autism therapy chain owned by private equity, has engaged in improper billing and child-abuse incidents.
A new watchdog report by the American Accountability Foundation accuses Hopebridge, a private-equity-owned autism-therapy provider that receives Medicaid payments, of systemic billing irregularities and child-abuse failures. Drawing on lawsuits, a federal settlement, staff accounts and investor property records, the 33-page dossier argues that the company’s staffing model places underpaid, underqualified workers in critical care roles, compromising the promised individualized treatment.
Since Arsenal Capital Partners bought Hopebridge in 2019, the chain has settled a $25,336.48 civil monetary penalty for submitting non-individualized care plans and has been sued over alleged overcharging and neglect, including a 2019 incident where a child was left alone in a windowless room and a 2023 case involving a technician’s sexual abuse confession. Although the provider has not been charged with healthcare fraud, the findings coincide with a broader federal crackdown on Medicaid fraud in autism services, highlighted by recent DOJ actions and CMS calls for tighter oversight. Hopebridge maintains it has served over 11,700 families and delivered more than 4.1 million therapy hours in 2025.
Why it matters
The report highlights potential misuse of public Medicaid funds and risks to vulnerable autistic children in private-equity-run clinics.
In this story
